TORONTO, ON – November 19, 2024 – The Canadian Nuclear Isotope Council (CNIC) is excited to announce that CUP Contract Labs, a German company offering contract laboratory services to clients across the radiopharmaceutical sector, has joined the CNIC as its newest international member organization. CUP Contract Labs was established in 1991 in the “Radiopharmaceutical Valley” … Read more
TORONTO, ON – November 15, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Telix Pharmaceuticals, an international biopharmaceutical company, as its newest member organization. Telix Pharmaceuticals (“Telix”) is a commercial-stage biotechnology company producing therapeutic and diagnostic radiopharmaceuticals currently involved in over 20 clinical trials globally and creating innovative radiometal technology within … Read more
TORONTO, ON – November 12, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that SAGE Engineering Services Ltd. has joined its growing network of leading Canadian supply chain companies. SAGE, an engineering firm established in 2000, operates out of Oakville, Ontario, and offers consultation, professional engineering, and compliance and validation services … Read more
Toronto, Ontario – October 23, 2024 – Yesterday, the Government of Ontario released Ontario’s Affordable Energy Future: The Pressing Case for More Power, which details the province’s rising energy demands and the government’s path to proactively managing this demand. The report also announced the upcoming release of Ontario’s first-ever Integrated Energy Plan to align the energy … Read more
TORONTO, ON — Following months of advocacy from the Canadian Nuclear Isotope Council (CNIC) and its industry partners, the Government of Ontario formally recognized the province’s leadership in the global nuclear isotope sector in today’s Phase 2 update to the government’s Life Sciences Strategy. In the CNIC’s 2023 Isotopes for Hope: Update on Recommendations report, … Read more
The Canadian Nuclear Isotope Council (CNIC) team had the pleasure of visiting Western University, in London, Ontario, to meet with leaders from across the University and local partner hospitals to learn about the innovative work on the production and use of medical isotopes in London. Our visit began at the Verspeeten Family Cancer Centre at … Read more
TORONTO, ON — September 9, 2024 – James Scongack, Chair of the Canadian Nuclear Isotope Council (CNIC), was awarded the King Charles III Coronation Medal last week, in recognition of his significant contributions to Ontario and Canada. In his role as Chief Operating Officer and Executive Vice President at Bruce Power, and as Chair of … Read more
Toronto – August 14, 2024 – With membership across the isotope supply chain, healthcare sector, and academic institutions, the Canadian Nuclear Isotope Council (CNIC) is committed to ensuring that the Canadian medical isotope industry is staffed with sufficient talent with the appropriate training to support its long-term leadership. The CNIC is pleased to announce that … Read more
Toronto – August 7, 2024 – As part of its mission to ensure patients across Canada have access to the highest standard of medical care and nuclear medicine services, the Canadian Nuclear Isotope Council (CNIC) is proud to announce its new collaboration with the More PETs Coalition. The More PETs Coalition is a group of … Read more
Toronto – July 16 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Agescan International Inc. (Agescan), bringing expertise in medical radiation shielding and strengthening the CNIC’s commitment to innovation and safety in the isotope industry. With customers around the world, Canadian-based Agescan is a rapidly-growing source of tungsten alloy and related … Read more